Novo Nordisk To Pay $100M To Settle Investor Class Action
Novo Nordisk announced Friday that it has reached a $100 million settlement in an investor class action alleging the Danish pharmaceutical giant boasted about its finances while concealing a scheme to...To view the full article, register now.
Already a subscriber? Click here to view full article